Cidara Therapeutics, Inc. (CDTX) SEC filings
CDTX SEC filings moved a median of +0.17% by the close. CDTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CDTX overview →
68 measured CDTX SEC filing events.
Where these CDTX SEC filings landedvs 63 measured CDTX SEC filing reactions
| Middle 50% of CDTX SEC filing reactions | -4.11% to +6.49% |
|---|---|
| Median reaction (to close) | +0.17% |
| Measured reactions | 63 |
Point-in-time · zero look-ahead
Half of the 63 CDTX SEC filing events with a measured close landed between -4.11% and +6.49%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Cidara Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Cidara Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Cidara Therapeutics, For: Jan 07 | SEC filing · Form 8-K | — | — | |
| Form POS AM Cidara Therapeutics, | SEC filing · Form POS | — | — | |
| Form S-8 POS Cidara Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Cidara Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +0.21% | +0.14% | |
| Form 10-Q Cidara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +4.75% | +6.21% | |
| Form 8-K Cidara Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +4.75% | +6.21% | |
| Form 8-K Cidara Therapeutics, For: Sep 30 | SEC filing · Form 8-K | -0.54% | -6.89% | |
| Form 8-K Cidara Therapeutics, For: Sep 24 | SEC filing · Form 8-K | +4.07% | +14.44% | |
| Form 10-Q Cidara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.71% | +7.29% | |
| Form 8-K Cidara Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +4.71% | +7.29% | |
| Form S-8 Cidara Therapeutics, | SEC filing · Form S-8 | +4.71% | +7.29% | |
| Form 8-K Cidara Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +1.74% | -1.82% | |
| Form 8-K Cidara Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +5.86% | +12.94% | |
| Form 8-K Cidara Therapeutics, For: Jun 23 | SEC filing · Form 8-K | -0.66% | +10.14% | |
| Form 8-K Cidara Therapeutics, For: Jun 18 | SEC filing · Form 8-K | -0.66% | +10.14% | |
| Form EFFECT Cidara Therapeutics, | SEC filing · Form EFFECT | +0.00% | +18.49% | |
| Form 10-Q Cidara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.08% | -11.16% | |
| Form 8-K Cidara Therapeutics, For: May 08 | SEC filing · Form 8-K | -4.08% | -11.16% | |
| Form S-3 Cidara Therapeutics, | SEC filing · Form S-3 | -4.08% | -11.16% | |
| Form ARS Cidara Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.88% | -2.91% | |
| Form DEF 14A Cidara Therapeutics, For: Jun 18 | SEC filing · Form DEF | -0.88% | -2.91% | |
| Form DEFA14A Cidara Therapeutics, | SEC filing · Form DEFA14A | -0.88% | -2.91% | |
| Form PRE 14A Cidara Therapeutics, For: Jun 18 | SEC filing · Form PRE | +0.00% | -2.34% | |
| Form 10-K Cidara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.19% | +8.28% | |
| Form 8-K Cidara Therapeutics, For: Mar 06 | SEC filing · Form 8-K | +1.19% | +8.28% | |
| Form S-8 Cidara Therapeutics, | SEC filing · Form S-8 | +1.19% | +8.28% | |
| Form 8-K Cidara Therapeutics, For: Feb 12 | SEC filing · Form 8-K | +0.83% | -0.54% | |
| Form 8-K Cidara Therapeutics, For: Jan 03 | SEC filing · Form 8-K | -4.53% | -9.86% | |
| Form EFFECT Cidara Therapeutics, | SEC filing · Form EFFECT | -3.50% | +0.70% | |
| Form S-1 Cidara Therapeutics, | SEC filing · Form S-1 | +0.00% | +0.73% | |
| Form 8-K Cidara Therapeutics, For: Nov 20 | SEC filing · Form 8-K | +0.00% | +3.43% | |
| Form 10-Q Cidara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.07% | +1.66% | |
| Form 8-K Cidara Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.07% | +1.66% | |
| Form 8-K Cidara Therapeutics, For: Sep 23 | SEC filing · Form 8-K | +0.00% | -2.77% | |
| Form 8-K Cidara Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +0.00% | +6.51% | |
| Form 10-Q Cidara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.40% | +2.55% | |
| Form 8-K Cidara Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -0.40% | +2.55% | |
| Form S-8 Cidara Therapeutics, | SEC filing · Form S-8 | -0.40% | +2.55% | |
| Form EFFECT Cidara Therapeutics, | SEC filing · Form EFFECT | — | -0.85% | |
| Form S-1 Cidara Therapeutics, | SEC filing · Form S-1 | +0.00% | +0.34% | |
| Form 8-K Cidara Therapeutics, For: Jul 18 | SEC filing · Form 8-K | -1.20% | -5.75% | |
| Form ARS Cidara Therapeutics, For: Dec 31 | SEC filing · Form ARS | — | -0.80% | |
| Form DEF 14A Cidara Therapeutics, For: Jul 18 | SEC filing · Form DEF | — | -0.80% | |
| Form DEFA14A Cidara Therapeutics, | SEC filing · Form DEFA14A | — | -0.80% | |
| Form PRE 14A Cidara Therapeutics, For: Jul 18 | SEC filing · Form PRE | +0.00% | +0.17% | |
| Form 8-K Cidara Therapeutics, For: May 14 | SEC filing · Form 8-K | — | -5.35% | |
| Form 10-Q Cidara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.73% | -2.28% | |
| Form 8-K Cidara Therapeutics, For: May 15 | SEC filing · Form 8-K | +0.73% | -2.28% | |
| Form D Cidara Therapeutics, | SEC filing · Form D | +0.00% | +8.02% | |
| Form 8-K Cidara Therapeutics, For: May 03 | SEC filing · Form 8-K | +5.87% | +6.47% | |
| Form 8-K/A Cidara Therapeutics, For: Apr 23 | SEC filing · Form 8-K | +0.00% | -1.80% | |
| Form 8-K Cidara Therapeutics, For: Apr 23 | SEC filing · Form 8-K | -1.72% | -10.35% | |
| Form S-8 Cidara Therapeutics, | SEC filing · Form S-8 | +0.81% | -5.30% | |
| Form 10-K Cidara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.81% | -5.30% | |
| Form 8-K Cidara Therapeutics, For: Apr 22 | SEC filing · Form 8-K | +0.81% | -5.30% | |
| Form 8-K Cidara Therapeutics, For: Apr 11 | SEC filing · Form 8-K | -0.59% | -14.12% | |
| Form 8-K Cidara Therapeutics, For: Apr 04 | SEC filing · Form 8-K | -5.54% | -10.83% | |
| Form NT 10-K Cidara Therapeutics, For: Dec 31 | SEC filing · Form NT | -1.24% | +19.48% | |
| Form DEF 14A Cidara Therapeutics, For: Apr 04 | SEC filing · Form DEF | -1.15% | +1.44% | |
| Form PRE 14A Cidara Therapeutics, For: Apr 04 | SEC filing · Form PRE | -3.59% | +2.76% | |
| Form 8-K Cidara Therapeutics, For: Feb 08 | SEC filing · Form 8-K | -1.15% | +7.06% | |
| Form 8-K Cidara Therapeutics, For: Dec 22 | SEC filing · Form 8-K | -2.07% | -6.63% | |
| Form 8-K Cidara Therapeutics, For: Nov 17 | SEC filing · Form 8-K | +1.29% | +1.30% | |
| Form 8-K Cidara Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -4.17% | +8.33% | |
| Form 10-Q Cidara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.12% | -8.99% | |
| Form 8-K Cidara Therapeutics, For: Nov 02 | SEC filing · Form 8-K | -1.12% | -8.99% |
Keep exploring
More CDTX: earnings → · analyst actions → · CDTX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Brookdale Senior Living Inc. (BKD) | 341 | +0.36% | 62% |
| Vaxart, Inc. (VXRT) | 341 | -0.81% | 41% |
| DaVita Inc. (DVA) | 339 | +0.07% | 53% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 339 | +0.29% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.